The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A retrospective cohort study.
 
Luca Mastrantoni
No Relationships to Disclose
 
Giovanna Garufi
No Relationships to Disclose
 
Noemi Maliziola
No Relationships to Disclose
 
Elena Di Monte
No Relationships to Disclose
 
Giorgia Arcuri
No Relationships to Disclose
 
Valentina Frescura
No Relationships to Disclose
 
Angelachiara Rotondi
No Relationships to Disclose
 
Giulia Giordano
No Relationships to Disclose
 
Luisa Carbognin
No Relationships to Disclose
 
Alessandra Fabi
No Relationships to Disclose
 
Ida Paris
No Relationships to Disclose
 
Fabio Marazzi
No Relationships to Disclose
 
Franco Antonio
No Relationships to Disclose
 
Gianluca Franceschini
No Relationships to Disclose
 
Armando Orlandi
No Relationships to Disclose
 
Antonella Palazzo
No Relationships to Disclose
 
Giovanni Scambia
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Speakers' Bureau - Clovis Oncology; MSD
 
Giampaolo Tortora
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Celgene; Dompé Farmaceutici; Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche